Posts: 32

Suresh PDMR

Latest Posts by the Author

  1. Formulation approaches and strategies for transdermal delivery of insulin: special emphasis on microneedle-based systems
  2. Therapeutic strategies targeting SREBP transcription factors
  3. Catapol: a promising natural neuroprotective agent for neurologic disorders
  4. PROTACs improve selectivity for targeted proteins
  5. Ferroptosis by nanomaterials: targeting cancer stem cells and overcoming drug resistance
  6. Revolutionizing HIV treatment: unveiling the new frontiers of HIV capsid research
  7. Discovery of wedelolactone from Eclipta Prostrata (L.) Linn. as a natural PDE4 inhibitor with potent anti-psoriasis effects
  8. Boosting pancreatic cancer chemotherapy by disrupting nerve–cancer crosstalk
  9. Moracin M derivative targeting PDE4 for the treatment of psoriasis
  10. Berberine inhibits phagocytosis through the TLR4-PI3K-CDC42 pathway
  11. Natural supramolecular photosensitizer with in situ switchable photothermal/photodynamic effects as an imaging platform for precise and controlled cancer synergistic therapy
  12. Coumarin derivatives as inhibitors against monoamine oxidase: structure-activity relationships and inhibitory mechanisms
  13. Randomized, waitlist-controlled trial of Cordyceps sinensis mycelium culture extract (Cs4) for long COVID patients in Hong Kong
  14. Pathologic and therapeutic insights into cholestatic liver disease-associated depressive disorder
  15. Exploring food and medicine homology: potential implications for cancer treatment innovations
  16. EGCG inhibits ferroptosis to ameliorate APAP-induced liver injury by suppressing NEDD8 and stabilizing HUWE1 in vivo and in vitro
  17. Antineoplastic effects of icaritin: molecular mechanisms and applications
  18. Progress in the structural modification and pharmacological activity of isosteviol
  19. Deciphering the regulatory programs of RNA binding proteins in rheumatoid arthritis through single-cell transcriptome analysis
  20. MiR-128-3p mediates MRP2 internalization in estrogen-induced cholestasis through targeting PDZK1